Dosing of LT4 in Older Individuals — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dosing of LT4 in Older Individuals — Stella

Recruiting

Back to Hypothyroidism trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Penn Medicine, Smilow Translational Research Center, Philadelphia, Pennsylvania

Key details

Phase

Post-approval study

Sponsor

University of Pennsylvania

Collaborators

National Institute on Aging (NIA)

Enrollment target

~228 participants

Started

January 2024

Primary completion

April 2028

Age range

65 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov